Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$306.88 - $380.0 $7.24 Million - $8.96 Million
-23,586 Reduced 3.85%
588,814 $223 Million
Q3 2023

Nov 08, 2023

SELL
$315.92 - $397.36 $17.1 Million - $21.5 Million
-53,989 Reduced 8.1%
612,400 $195 Million
Q2 2023

Aug 09, 2023

SELL
$346.15 - $392.09 $14.1 Million - $16 Million
-40,735 Reduced 5.76%
666,389 $256 Million
Q1 2023

May 10, 2023

SELL
$323.56 - $373.36 $23.5 Million - $27.1 Million
-72,488 Reduced 9.3%
707,124 $264 Million
Q4 2022

Feb 13, 2023

SELL
$248.67 - $334.17 $7.28 Million - $9.79 Million
-29,284 Reduced 3.62%
779,612 $258 Million
Q3 2022

Nov 09, 2022

SELL
$263.81 - $337.27 $38.3 Million - $48.9 Million
-145,024 Reduced 15.2%
808,896 $213 Million
Q2 2022

Aug 09, 2022

SELL
$301.4 - $428.42 $28.3 Million - $40.3 Million
-93,995 Reduced 8.97%
953,920 $299 Million
Q1 2022

May 11, 2022

SELL
$379.46 - $424.54 $34.5 Million - $38.7 Million
-91,041 Reduced 7.99%
1,047,915 $438 Million
Q4 2021

Feb 10, 2022

SELL
$373.53 - $434.12 $8.96 Million - $10.4 Million
-23,975 Reduced 2.06%
1,138,956 $477 Million
Q3 2021

Nov 10, 2021

SELL
$396.76 - $455.92 $16.5 Million - $19 Million
-41,707 Reduced 3.46%
1,162,931 $481 Million
Q2 2021

Aug 13, 2021

SELL
$372.36 - $412.07 $46.2 Million - $51.2 Million
-124,150 Reduced 9.34%
1,204,638 $477 Million
Q1 2021

May 13, 2021

SELL
$357.26 - $392.57 $18.2 Million - $20 Million
-51,042 Reduced 3.7%
1,328,788 $510 Million
Q4 2020

Feb 12, 2021

SELL
$319.05 - $363.32 $56.7 Million - $64.6 Million
-177,855 Reduced 11.42%
1,379,830 $501 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $33.4 Million - $41.5 Million
-119,194 Reduced 7.11%
1,557,685 $525 Million
Q2 2020

Nov 20, 2020

BUY
$270.93 - $320.3 $2.75 Million - $3.25 Million
10,152 Added 0.61%
1,676,879 $476 Million
Q2 2020

Aug 11, 2020

SELL
$270.93 - $320.3 $28.4 Million - $33.5 Million
-104,723 Reduced 5.91%
1,666,727 $473 Million
Q1 2020

Nov 20, 2020

BUY
$243.44 - $359.98 $2.58 Million - $3.82 Million
10,600 Added 0.6%
1,771,450 $488 Million
Q1 2020

May 14, 2020

SELL
$243.44 - $359.98 $36.4 Million - $53.9 Million
-149,720 Reduced 7.84%
1,760,850 $485 Million
Q4 2019

Nov 25, 2020

BUY
$281.18 - $322.05 $3.26 Million - $3.73 Million
11,588 Added 0.61%
1,910,570 $614 Million
Q4 2019

Feb 13, 2020

SELL
$281.18 - $322.05 $28.7 Million - $32.8 Million
-102,001 Reduced 5.1%
1,898,982 $610 Million
Q3 2019

Nov 20, 2020

BUY
$294.25 - $341.49 $3.52 Million - $4.08 Million
11,946 Added 0.6%
2,000,983 $594 Million
Q3 2019

Nov 05, 2019

SELL
$294.25 - $341.49 $51 Million - $59.2 Million
-173,307 Reduced 8.01%
1,989,037 $591 Million
Q2 2019

Aug 14, 2019

SELL
$279.29 - $336.89 $25.2 Million - $30.4 Million
-90,257 Reduced 4.01%
2,162,344 $728 Million
Q1 2019

May 13, 2019

SELL
$246.18 - $297.25 $108 Million - $131 Million
-439,512 Reduced 16.33%
2,252,601 $667 Million
Q4 2018

Feb 08, 2019

SELL
$232.7 - $281.66 $22.5 Million - $27.2 Million
-96,669 Reduced 3.47%
2,692,113 $685 Million
Q3 2018

Oct 25, 2018

SELL
$236.3 - $277.15 $62.8 Million - $73.6 Million
-265,636 Reduced 8.7%
2,788,782 $773 Million
Q2 2018

Jul 30, 2018

BUY
$217.98 - $237.23 $70.5 Million - $76.8 Million
323,559 Added 11.85%
3,054,418 $719 Million
Q1 2018

May 04, 2018

BUY
$218.74 - $251.43 $26.2 Million - $30.2 Million
119,970 Added 4.59%
2,730,859 $625 Million
Q4 2017

Feb 14, 2018

SELL
$217.88 - $244.43 $14.4 Million - $16.1 Million
-65,987 Reduced 2.47%
2,610,889 $569 Million
Q3 2017

Nov 14, 2017

SELL
$231.6 - $253.39 $122 Million - $133 Million
-524,789 Reduced 16.39%
2,676,876 $635 Million
Q2 2017

Aug 14, 2017

BUY
N/A
3,201,665
3,201,665 $767 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.61B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.